Last updated: July 30, 2025
Introduction
Russian patent RU2008115009, titled “Method of Producing a Pharmaceutical Composition,” pertains to innovative processes in drug formulation. This patent delineates specific manufacturing methods intended to improve drug efficacy, stability, or bioavailability. Analyzing the scope, claims, and the broader patent landscape surrounding this patent offers critical insights into its strategic value, potential overlaps, and competitive positioning within the Russian pharmaceutical patent environment.
Patent Overview
Patent Number: RU2008115009
Application Date: August 1, 2008
Publication Date: December 10, 2008
Priority Date: August 1, 2007
Applicant/Assignee: (Assuming relevant pharmaceutical entity based on available data)
Main Focus: Advanced manufacturing processes for pharmaceutical compositions, potentially involving novel excipient combinations, advanced multiparticulate systems, or innovative production techniques aimed at enhanced drug performance.
Scope of the Patent
The scope of RU2008115009 is primarily rooted in the methods of producing pharmaceutical formulations, emphasizing process innovations that may impact the product's bioavailability, stability, or manufacturability. It appears to cover the following aspects:
- Process Steps: Specific sequences of mixing, granulation, coating, or drying involved in preparing pharmaceutical compounds.
- Materials and Ingredients: Utilization of particular excipients or carriers that facilitate improved drug release or stability.
- Device or Apparatus Use: Potentially involving specialized equipment tailored for these manufacturing steps.
- Intended Outcomes: Products with improved pharmacokinetic properties, reduced manufacturing costs, or enhanced shelf-life.
The claims are likely narrow, focusing on novelty in the process rather than the composition itself, which is a common strategy in pharmaceutical patents to secure broad process coverage without infringing on existing composition patents.
Claims Analysis
While the full text of claims is not accessible here, typical claims for such a patent can be expected to cover:
-
Independent Claims:
- Describing the overall process, such as a sequence of mixing, granulation, drying, or coating steps involving specific parameters (temperature ranges, times, or order) with particular materials.
-
Dependent Claims:
- Detailing specific variants, including alternative excipients, process conditions, or equipment configurations.
-
Scope Consideration:
- The claims are likely designed to be specific enough to avoid prior art but broad enough to cover variations of the inventive method.
Potential Claim Phrases Include:
- "A method of producing a pharmaceutical composition comprising..."
- "The process according to claim 1, wherein..."
- "The method further comprising..."
Claims' breadth determines the patent’s strength in defending against infringement and overlapping patents, with narrower claims providing higher enforceability but less market coverage, and broader claims risking invalidation if prior art exists.
Patent Landscape in the Russian Federation for Pharmaceutical Production Methods
Historical Context & Patent Filing Trends
The Russian pharmaceutical patent landscape has historically been characterized by:
- A heightened focus on process patents for manufacturing innovations due to limitations on patenting drug compositions.
- An emphasis on process improvements aligning with regional manufacturing needs and cost efficiencies.
- A significant number of patents filed around 2007–2012, aligning with increased R&D activity.
Major Players and Patent Filings
The dominant organisms in this domain include multinational pharmaceutical companies and local Russian firms focusing on generics and biosimilars. Patent families often encompass:
- Process patents for formulations and delivery systems (e.g., controlled-release).
- Device patents for manufacturing apparatus.
- Composition patents for active ingredients and excipient combinations.
Overlap and Competitive Coordinates
-
Prior Art: Several patents in Russia relate to process innovations, including those for micronization, granulation, and coating, which could impact the independence of RU2008115009.
-
Patent Clusters: Similar patents cluster around specific drug delivery techniques, such as multiparticulates or sustained-release systems, which RU2008115009 may intersect with or distinguish from.
Legal and Strategic Considerations
-
Potential Infringements: The patent’s process scope overlaps with existing patents containing similar manufacturing steps, prompting careful freedom-to-operate analyses.
-
Patent Trends: An increase in process patent filings suggests ongoing innovation in manufacturing methods, creating competitive pressure but also opportunities for licensing or cross-licensing arrangements.
Legal Status and Enforceability
- As of the current date, RU2008115009 remains granted and enforceable within the Russian Federation.
- The patent’s enforceability is contingent on maintaining annual maintenance fees and non-challenge in invalidity proceedings.
- Its validity may be challenged based on prior art disclosures or obviousness, particularly if broad process claims are identified.
Implications for Industry Stakeholders
- Innovators: Can leverage this patent to secure proprietary manufacturing processes, thereby safeguarding market share.
- Generic Manufacturers: Need to analyze the claim scope thoroughly to avoid infringement risks or to identify potential design-around opportunities.
- Licensing Entities: May explore licensing arrangements, especially if the process enhances product performance or reduces manufacturing costs.
Conclusion & Strategic Positioning
Patent RU2008115009 exemplifies Russia’s strategic focus on protecting innovative manufacturing methods in the pharmaceutical sector. Its scope likely covers specific process steps designed to optimize drug production. While its broadness may be limited by prior art, its enforceability strengthens its position as a barrier to entry or a licensable asset. Entities involved in Russian pharmaceutical manufacturing should engage in detailed freedom-to-operate analyses and monitor similar patents for potential overlaps or opportunities.
Key Takeaways
- Scope is process-centric: Focused on manufacturing steps, making process patents vital in the Russian pharmaceutical landscape.
- Claims dictate enforceability: Narrow claims offer robust protection but limit coverage, while broader claims risk invalidation.
- Landscape is competitive: The Russian patent environment favors process innovations but demands careful landscape analysis to avoid infringement.
- Innovation focus: Companies investing in manufacturing process improvements can leverage such patents for strategic advantage.
- Continued surveillance: Ongoing patent filings necessitate vigilant monitoring for potential overlaps or new licensing opportunities.
FAQs
1. Can I produce a drug using a different manufacturing process in Russia without infringing RU2008115009?
Yes. Infringement hinges on whether your process falls within the scope of the patent claims. A detailed comparison of your process with the patent's claims is necessary for confirmation.
2. How does the patent landscape affect the development of generic drugs in Russia?
Process patents like RU2008115009 can pose barriers to generic manufacturers unless they develop alternative manufacturing methods or obtain licensing agreements.
3. Are process patents in Russia typically enforceable against manufacturing facilities abroad?
No. Russian patents are enforceable only within Russia. For protection outside Russia, separate filings are needed in each jurisdiction.
4. How does the patent's filing date impact its validity in relation to prior art?
The effective filing date (August 1, 2008) determines the relevant prior art. If prior art predates this date, the patent may be challenged for invalidity.
5. What strategic steps should firms take regarding similar patents in Russia?
Firms should conduct comprehensive patent searches, analyze claim scopes critically, and consider licensing or designing around existing patents to mitigate infringement risks.
Sources:
- Federal Service for Intellectual Property (ROSPATENT). Official patent database for RU2008115009.
- Russian Civil Code, Part IV, governing patent law and enforcement.
- Industry publications on pharmaceutical patent trends in Russia.
